Title:
DRUG THERAPY FOR CELIAC SPRUE
Document Type and Number:
WIPO Patent Application WO2003096979
Kind Code:
A3
Abstract:
Administering an effective dose of a tTGase inhibitor to a Celiac or dermatitis herpetiformis patient reduces the toxic effects of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects of gluten.
More Like This:
| JP2010150268 | CALCIUM RECEPTOR MODULATING AGENT |
| WO/2021/034414 | MODULATION OF DENDRITIC CELL FUNCTION BY THE PHOSPHOLIPID MESSENGER LPA |
| WO/2012/011125 | AGONISTS OF GPR40 |
Inventors:
KHOSLA CHAITAN (US)
HAUSCH FELIX (CH)
PARROT ISABELLE (FR)
SHAN LU (US)
HAUSCH FELIX (CH)
PARROT ISABELLE (FR)
SHAN LU (US)
Application Number:
PCT/US2003/015343
Publication Date:
February 12, 2004
Filing Date:
May 14, 2003
Export Citation:
Assignee:
UNIV LELAND STANFORD JUNIOR (US)
KHOSLA CHAITAN (US)
HAUSCH FELIX (CH)
PARROT ISABELLE (FR)
SHAN LU (US)
KHOSLA CHAITAN (US)
HAUSCH FELIX (CH)
PARROT ISABELLE (FR)
SHAN LU (US)
International Classes:
A61K31/42; A61K38/48; C07D261/04; C07D413/12; (IPC1-7): A61K38/00
Foreign References:
| US6410550B1 | 2002-06-25 | |||
| US5834428A | 1998-11-10 |
Other References:
See also references of EP 1507549A4
Download PDF: